Literature DB >> 21294809

Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.

Kaylene Ready, Angelica M Gutierrez-Barrera, Christopher Amos, Funda Meric-Bernstam, Karen Lu, Gabriel Hortobagyi, Banu Arun.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21294809     DOI： 10.1111/j.1524-4741.2010.01055.x

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  13 in total

1.  BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

Authors:  Noralane M Lindor; David E Goldgar; Sean V Tavtigian; Sharon E Plon; Fergus J Couch
Journal:  Oncologist       Date:  2013-04-24

Review 2.  BRCA-associated ovarian cancer: from molecular genetics to risk management.

Authors:  Giulia Girolimetti; Anna Myriam Perrone; Donatella Santini; Elena Barbieri; Flora Guerra; Simona Ferrari; Claudio Zamagni; Pierandrea De Iaco; Giuseppe Gasparre; Daniela Turchetti
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

3.  Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.

Authors:  Ji Soo Park; Eun Ji Nam; Hyung Seok Park; Jung Woo Han; Jung-Yun Lee; Jieun Kim; Tae Il Kim; Seung-Tae Lee
Journal:  Cancer Res Treat       Date:  2017-01-17       Impact factor: 4.679

4.  The influence of BRCA variants of unknown significance on cancer risk management decision-making.

Authors:  Jing Yi Chern; Sarah S Lee; Melissa K Frey; Jessica Lee; Stephanie V Blank
Journal:  J Gynecol Oncol       Date:  2019-02-27       Impact factor: 4.401

Review 5.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

6.  Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.

Authors:  Daniele Fanale; Alessia Fiorino; Lorena Incorvaia; Alessandra Dimino; Clarissa Filorizzo; Marco Bono; Daniela Cancelliere; Valentina Calò; Chiara Brando; Lidia Rita Corsini; Roberta Sciacchitano; Luigi Magrin; Alessia Pivetti; Erika Pedone; Giorgio Madonia; Alessandra Cucinella; Giuseppe Badalamenti; Antonio Russo; Viviana Bazan
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 5.738

7.  Understanding of BRCA VUS genetic results by breast cancer specialists.

Authors:  B K Eccles; E Copson; T Maishman; J E Abraham; D M Eccles
Journal:  BMC Cancer       Date:  2015-11-25       Impact factor: 4.430

8.  A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.

Authors:  Eliseos J Mucaki; Natasha G Caminsky; Ami M Perri; Ruipeng Lu; Alain Laederach; Matthew Halvorsen; Joan H M Knoll; Peter K Rogan
Journal:  BMC Med Genomics       Date:  2016-04-11       Impact factor: 3.063

Review 9.  New challenges for BRCA testing: a view from the diagnostic laboratory.

Authors:  Andrew J Wallace
Journal:  Eur J Hum Genet       Date:  2016-09       Impact factor: 4.246

10.  BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

Authors:  Bárbara Alemar; Cleandra Gregório; Josef Herzog; Camila Matzenbacher Bittar; Cristina Brinckmann Oliveira Netto; Osvaldo Artigalas; Ida Vanessa D Schwartz; Jordy Coffa; Suzi Alves Camey; Jeffrey Weitzel; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.